Comparison of digital PCR platforms and semi-nested qPCR as a tool to determine the size of the HIV reservoir by Bosman, Kobus J et al.
1Scientific RepoRts | 5:13811 | DOi: 10.1038/srep13811
www.nature.com/scientificreports
Comparison of digital PCR 
platforms and semi-nested qPCR 
as a tool to determine the size of 
the HIV reservoir
KJ Bosman1, M Nijhuis1, PM van Ham1, AMJ Wensing1, K Vervisch2, L Vandekerckhove2 & 
W De Spiegelaere2
HIV persists in latently infected cells of patients on antiretroviral therapy (ART). This persistent 
proviral DNA reservoir is an important predictor of viral rebound upon therapy failure or interruption 
and forms a major obstacle towards cure. Accurate quantification of the low levels of persisting HIV 
DNA may aid patient monitoring and cure research. Digital PCR is a promising tool that enables 
direct absolute quantification with high sensitivity. With recent technological advances, several 
platforms are available to implement digital PCR in a clinical setting. Here, we compared two digital 
PCR platforms, the Quantstudio 3D (Life Technologies) and the QX100 (Bio-Rad) with a semi-nested 
qPCR on serial HIV DNA dilutions and DNA isolated from PBMCs of ART-suppressed patients. All 
three methods were able to detect target to the lowest levels of 2.5 HIV DNA copies. The QX100 
excelled in having the least bias and highest precision, efficiency and quantitative linearity. Patient 
sample quantifications by the QX100 and semi-nested qPCR were highly agreeable by Bland-Altman 
analysis (0.01 ± 0.32 log10). Due to the observation of false-positive signals with current digital PCR 
platforms however, semi-nested qPCR may still be preferred in a setup of low quantity detection to 
discriminate between presence or absence of HIV DNA.
Current treatment of HIV depends on the use of antiretroviral drugs that block different steps in the HIV 
replication cycle. To verify that ART is successfully suppressing HIV replication, patients are routinely 
monitored for the abundance of HIV particles in their bloodstream by quantification of viral RNA in 
plasma. However, despite effective viral suppression in plasma, the virus remains present in a so-called 
latent reservoir of infected cells harboring replication competent proviral HIV DNA in their genome1,2. 
Consequently, HIV RNA quantification in plasma is inadequate to monitor the size and dynamics of the 
latent HIV DNA reservoir.
Total cellular HIV DNA has been proposed as an alternative marker to measure the size of the latent 
reservoir. The predictive role of HIV DNA as a marker of the replication competent reservoir is debat-
able because most HIV DNA is replication deficient3. However, accumulating clinical data indicate that 
HIV DNA can be used as a marker in cure research and patient monitoring to predict remission of HIV 
after treatment with ART or other therapies directed at eradicating the latent reservoir. The size of the 
HIV DNA reservoir was shown to correlate with the time to viral rebound4,5 and the viraemia setpoint6 
upon ART interruption. In agreement with these findings, a recent clinical trial in humans found that 
reductions in HIV DNA levels were associated with durable viral suppression after ART treatment inter-
ruption following a pegylated interferon alfa-2a stimulation7. In addition, HIV DNA levels are predictive 
of disease progression in untreated patients8,9, even more so than plasma viral RNA load5. Together, 
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these findings indicate the importance of HIV DNA quantification as a marker for HIV disease and 
persistence research.
Because of the low frequency of proviral HIV DNA in immune cells from the peripheral blood and 
tissue compartments, future clinical management and cure research will benefit from a system that can 
reliably quantify HIV DNA in patients. The system should specifically be able to detect low copy num-
bers as often observed in long-term ART-suppressed patients3 and in patients who underwent stem-cell 
transplantation in an attempt to clear the viral reservoir10. To date, most quantification techniques make 
use of real-time quantitative PCR (qPCR) to detect and quantify HIV DNA. However, interpretation of 
the resulting relative quantification to absolute quantities requires a standard dilution. This may intro-
duce quantitative bias when PCR efficiencies are variable between samples. Variable PCR efficiencies are 
likely to occur in HIV-infected patients, as variations in the target sequence that lead to mismatches in 
the primer and/or probe sequence can affect PCR efficiency. Moreover, qPCR inaccuracy increases with 
lower target abundance due to the logarithmic nature of PCR11, thereby potentially complicating reliable 
quantification of the lowly abundant HIV DNA found in ART-suppressed patients.
The recent development of digital PCR (dPCR) platforms is a promising step forward, as this tech-
nology provides absolute quantification of DNA without the need of a standard curve and with a better 
tolerance to PCR inhibitors compared to qPCR12. Instead of measuring the real-time increase of fluores-
cence intensity within one sample, dPCR measures the end-point fluorescence of a large number of PCR 
partitions of the same sample in the limiting dilution range. By applying Poisson-statistics, the fraction of 
positive partitions is used as a measure for the number of targets in the sample, allowing direct absolute 
quantification13.
Although the concept of dPCR has been around for several decades, technological advances are 
now enabling a broad use of this technology13–17. The Droplet Digital™ PCR system (Bio-Rad) and 
the RainDrop® Digital PCR system (RainDance Technologies) use microfluidics based droplet in oil 
solutions to make PCR partitions14,18,19. The QuantStudio® 3D Digital PCR system (Life Technologies) 
divides the PCR partitions in a grid of wells, after which the PCR reaction takes place and the microchip 
is interpreted in a separate read-out unit20–23. DPCR has previously been described to provide absolute 
quantification of HIV with a sensitivity similar to or better than qPCR as shown in studies that assessed 
HIV RNA24, cell-associated HIV RNA25, total HIV DNA26–29 and HIV DNA 2-LTR circles26,29,30.
In the present study, we compared two differently operating dPCR platforms with a highly sensitive 
semi-nested qPCR for detecting lowly abundant HIV DNA copies. We used an identical primer-probe 
set for the most direct comparison between Bio-Rad’s QX100™ Droplet Digital™ PCR System, Life 
Technologies™ QuantStudio® 3D Digital PCR system and a semi-nested qPCR assay. HIV DNA copy 
abundance was measured in both an artificial dilution series and in HIV-infected patient samples.
Materials and Methods
Patient samples. Ethical approval was obtained from the Ethics Committees of the University Hospital 
Ghent (ref. nr. B670201111928), all participants provided written informed consent and all experiments 
were performed in accordance with the approved guidelines and regulations. To assess performance on 
patient-derived samples, the abundance of total cellular HIV DNA was measured with all three meth-
ods in 20 ART-suppressed patients with undetectable plasma loads (< 40 copies/mL). Peripheral blood 
mononuclear cells (PBMCs) were isolated from fresh blood by Ficoll gradient centrifugation and stored 
as dry pellets at − 80 °C until further processing. As negative template control samples, water NTCs (no 
template controls) were used and PBMCs from HIV-negative healthy donors as PBMC DNA NTCs.
DNA extraction and digestion. Total DNA was extracted from 5–10 × 106 PBMCs or U1 cells using 
the DNeasy® mini kit (Qiagen, Venlo, The Netherlands) using the standard protocol with an elution 
buffer (45 μ l per sample) preheated at 56 °C for 5 min to increase the yield of the isolation procedure.
U1 dilution series. In the first part of this study, a U1 cell line was diluted to construct a dilution 
series ranging from 160 to 2.5 HIV DNA copies per sample. The U1 cell line31,32, containing two HXB2/
Lai HIV provirus integrations per cell33, was obtained from the NIH AIDS Reagent Program, Division 
of AIDS, NIAID. The cells were cultured in RPMI1640 with L-glutamine (Lonza), 10% Fetal Calf Serum 
(FCS, Sigma-Aldrich) and 10 μ g/ml gentamicin (Invitrogen)32. After isolation, the DNA yield was meas-
ured by Qubit and diluted to contain 160 copies per 1.6 μ l (0.264 ng/μ l). This sample was used to create 
a two-fold dilution of samples containing 160, 80, 40, 20, 10, 5 and 2.5 HIV copies per 0.9 μ l. Cell 
numbers were deduced from the amount of DNA, assuming a mean molecular weight of 615 Dalton or 
1.023E-9 pg per nucleotide pair and a human genome length of 3234 Mb, the genome of one diploid U1 
cell weighs 6.6 pg. As the U1 cell line carries two proviral HIV copies, 3.3 pg of U1 DNA should on aver-
age contain one HIV copy34. All samples were supplemented with HIV-negative donor PBMC DNA to 
standardize the level of total cellular DNA in all dilutions by supplementing to 1000 ng of donor PBMC 
DNA (the equivalent of ~150.000 cells) to a final concentration of the desired input copy numbers per 
1.6 μ l. Part of every dilution was digested with EcoRI (Roche Diagnostics) to prepare the samples for 
dPCR. Restriction digestion was performed by adding 0.2 μ l of the EcoRI enzyme (10 U/μ l) and 0.2 μ l 
10x buffer H to every 1.6 μ l of sample. The undigested part of the dilution series was supplemented 
with a volume of water equal to that of the digestion mix, thereby also diluting the sample 1.25 times to 
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ultimately contain the desired input copy numbers per 2 μ l for measurement in the qPCR. The samples 
were measured in triplicate by each of the three methods (a total of 9 samples measured per dilution).
Primers and probes. The same primer-probe set was used for all platforms. These prim-
ers amplify a part of the HIV genome that codes for capsid p24 using the gag1 assay. Gag_forward 
(5′ -TGGGTAAAAGTAGTAGAAGAGAAGGCTTT-3′ ) was used as the forward primer and Gag_
reverse (5′ -CCCCCCACTGTGTTTAGCAT-3′ ) as the reverse primer. The gag1 assay uses the Taqman 
minor groove binding (MGB) FAM-probe Gag_MGB (5′ -TCAGCATTATCAGAAGGAG-3′ ), which 
maps in between the two gag1 primers. The assay was only semi-nested in the real-time PCR, using 
the Gag_forward primer and a reverse primer located 3′ of the Gag_reverse primer, named 3′ MA-1 
(5′ -GCTATGTCACTTCCCCTTGGTTCT-3′ ). As the primers were designed for subtype B, none of 
the primers have any mismatches with the HXB2 reference genome that was used to make the U1 
cell line. Mismatches were found with the three subtype B reference genomes used in the HIV LANL 
subtype reference alignment (http://www.hiv.lanl.gov/content/sequence/QUICK_ALIGNv2/QuickAlign.
html): B.NL.00.671_00T36.AY423387, B.TH.90.BK132.AY173951 and B.US.98.1058_11.AY331295. The 
Gag_forward primer has one mismatch in each of the three subtype B reference genomes, the Gag_MGB 
FAM-probe and the 3′ MA-1 primer have one mismatch in one of the three reference genomes, and the 
Gag_reverse primer has no mismatches to any of the three reference genomes.
QX100 dPCR. The reaction mix used to quantify in the QX100™ Droplet Digital™ PCR System 
(Bio-Rad), further referred to as the QX100, consisted of 10 μ l 2x ddPCR™ super mix for probes 
(Bio-Rad), 800 nM primers, 300 nM probe and 2 μ l of the restriction digest, into a final volume of 20 μ l. 
Droplets were generated in the droplet generator (Bio-Rad) and PCR was performed in a T100™ thermal 
cycler (Bio-Rad). PCR amplification procedure consisted of an initial denaturation at 95 °C for 5 min, 
and 39 cycles of denaturation at 95 °C for 30 sec and annealing/elongation at 58 °C for 1 min. After PCR, 
read-out of positive versus negative droplets was performed with the droplet reader.
Quantstudio 3D dPCR. The samples that were measured by the™ QuantStudio® 3D Digital PCR 
System (Life Technologies), further referred to as the Quantstudio, were loaded onto the chips using the 
QuantStudio® 3D Digital PCR Chip Loader in a mixture consisting of 2x Quantstudio® 3D digital PCR 
mastermix, 300 nM of Gag_foward primer, 300 nM of Gag_reverse primer and 300 nM of Gag_MGB 
probe. The chips were sealed and loaded onto a GeneAMP® PCR system 9700 (Applied Biosystems®) 
and cycled according to the following parameters: 96 °C for 10 minutes, followed by 39 cycles of 60 °C 
for 2 min and 98 °C for 30 sec, and a final extension at 60 °C for 2 min. After cycling, the end-point fluo-
rescence of the partitions on the chips was measured by transferring the chips to the measurement unit 
(application version 1.1.3, algorithm version 0.13).
Semi-nested real-time PCR. The real-time PCR uses two rounds of PCR amplification of the 
gag-region of p24. The first PCR is performed in a T100™ PCR machine (Bio-Rad) in a 25 μ l mix con-
taining 2 μ l of DNA sample, 2.5 μ l 10x home-brewed OT buffer (670 mM TrisHCl, 170 mM (NH4)2SO4, 
10 mM β -Mercaptoethanol, 60 μ M EDTA, 2 mg/mL BSA), 200 nM dNTPs, 2 mM MgCl2, 0.65 units 
DreamTaq polymerase (Promega) and 200 nM Gag_forward and 200 nM 3′ MA-1 primers. The cycling 
parameters were: 94 °C for 3 min, followed by 15 cycles of 94 °C for 30 sec, 55 °C for 30 seconds and 72 °C 
for 1 min, and finally 72 °C for 5 min. The nested PCR was then performed on an Applied Biosystems® 
StepOnePlus™ Real-Time PCR system (which we will now call qPCR) with 5 μ l of the first PCR as 
the template for the nested mix containing 12.5 μ l of 2x Taqman mix, 300 nM of Gag_forward primer, 
300 nM of Gag_reverse primer and 300 nM of Gag_MGB probe. The real-time cycling parameters were 
50 °C for 2 min, 95 °C for 10 min, followed by 40 cycles of 95 °C for 15 sec and 60 °C for 1 min.
Data analysis. Raw data analysis was performed with the specific software for each of the three plat-
forms, i.e. QuantaSoft (version 1.3.2.0) for the QX100, Quantstudio 3D Analysis Suite Cloud Software 
v1.0 for the Quantstudio (https://apps.lifetechnologies.com/quantstudio3d) and StepOne Software v2.3 
for qPCR. For the QX100 a common threshold was set at a fixed fluorescence intensity of 3000 based on 
the PBMC DNA NTCs and this threshold was used to assess all QX100 partitions. For the Quantstudio 
quantifications, automated threshold setting proved highly unreliable for the smallest input samples, 
and the analysis software does not enable direct comparison of the samples, thereby creating user bias 
when manually setting one uniform threshold. For this study, the threshold was user-defined at 4000. 
For qPCR, the Cq threshold was manually set at 0.025 for all samples of the dilution series experiment 
and at 0.029 for all samples of the patient material comparison. Bias was defined as the difference (in 
percent) of observed quantity from the expected quantity.
To compare precision between the three systems, we calculated the coefficient of variation (CV), 
which is the proportion of the standard deviation in relation to the mean, expressed as a percentage. 
The CV provides a rough estimation of the capability of the systems to produce reproducible quantities 
for three replicates that should contain the same number of targets. To be able to calculate CVs for the 
lowest input range, we replaced the results of replicates for which no target could be detected with 40 in 
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case of qPCR and with 0.01 in case of digital PCR, but it should be noted that these undetermined results 
unrightfully increase the CV whereas an undetermined result may in fact be due to sampling error.
For the semi-nested qPCR, a transformation of the raw Cq data was performed to allow direct com-
parison of CV between the logarithmical output of the semi-nested qPCR and the linear dPCR output11. 
The Cqs were transformed to relative quantities by normalizing each Cq against the average Cq of the 
highest input sample (∆Cq) and using the empirically defined efficiency to calculate relative quantities 
using the formula q = 1/E∆Cq (with q the relative quantity and E the PCR efficiency).
Quantitative linearity and efficiency of the measurements in the dilution series was assessed using 
robust regression analysis. Simple linear regression greatly suffers from outliers that may pull the regres-
sion towards their coordinates, whereas robust regression analysis is less susceptible to single outliers and 
provides a more efficient estimation of the slope of a dilution curve35. Robust regression was analyzed by 
using the biweight MM estimation which is an estimator that was demonstrated to be less influenced by 
outliers in the extremes of the standard curves35. Robust regression analysis was performed in R, using 
the lmRob package.
Agreement between the different methods for quantifying the same patient samples was assessed by 
Bland-Altman analysis. Bland-Altman analysis compares every observation of two methods by plotting 
the difference between observations against their average value. In the low ranges of the dilution series, 
errors of random sampling can increase variation between technical replicates36. To analyze the results 
without interference of the sampling error, all patient samples for which no target could be detected in 
one or more replicates by any method were excluded. Bland-Altman analysis was performed in R using 
custom scripts.
Ethical approval was obtained from the Ethics Committees of the University Hospital Ghent (ref. nr. 
B670201111928), all participants provided written informed consent and all experiments were performed 
in accordance with the approved guidelines and regulations.
Results
Detection of HIV DNA in the U1 dilution series. All three methods were able to detect dilutions 
with high concentrations of HIV DNA (Table  1). The semi-nested qPCR only delivered a detectable 
signal for one replicate of the 5-copy dilution and for two replicates of the 2.5 copy sample. Semi-nested 
qPCR was completely negative in the PBMC DNA NTCs and in water NTCs. The QX100 was negative 
for one replicate in the 2.5 copy dilution and for all three replicates of the PBMC DNA NTCs (Table 1). 
Table 1.  Dilution series output of the three methods. The qPCR data is provided as Cq values and as 
transformed absolute values (relative to the standard curve) for comparison with the quantitative data of the 
dPCR platforms. Replicates for which no target could be detected were assigned a value of 0.01 in case of  
the digital platforms and a Cq of 40 in case of the qPCR and are indicated with red outlining. The resulting 
mean, bias, standard deviation and coefficient of variation of those samples are in bold to indicate that they 
have been influenced by the undetected replicates.
www.nature.com/scientificreports/
5Scientific RepoRts | 5:13811 | DOi: 10.1038/srep13811
The Quantstudio detected input in every single replicate of the dilution series, including the PBMC DNA 
NTCs and water NTCs (Supplementary Table S1).
In terms of precision (variation between technical replicates), the QX100 and the Quantstudio per-
formed comparably; neither of the methods had a consistently higher or lower coefficient of variation 
(CV). A comparison of the CVs from the relative qPCR quantities with the output of the dPCR platforms 
revealed that the qPCR was less accurate compared to the QX100 and the Quantstudio (Table 1).
Both dPCR platforms overestimated the expected dilution series quantities (bias 8.1% for the QX100 
and 28.8% for the Quantstudio) (Fig. 1). The observed quantities from the QX100 were closer to the input 
quantities compared to the Quantstudio for every step in the dilution series (Table 1). The Quantstudio 
overestimated the two dilutions with the least input DNA most severely, possibly due to the false-positive 
reactions that were also observed in the PBMC DNA NTCs and water NTCs (Supplementary Table S1). 
The semi-nested qPCR could not be assessed for bias because its absolute quantification depends on a 
relative quantification based on the standard itself.
Quantification efficiency (E) as derived from the slope of the robust regression trend line was E = 74%, 
93.6% and 104.5% with the Quantstudio, the semi-nested qPCR and the QX100 respectively (Fig.  1). 
Omitting undetermined values, the R2 amounted to 0.78 for the Quantstudio, 0.83 for the qPCR and 
0.85 for the QX100.
Detection of HIV DNA in patient samples. The detectability of HIV DNA copies in HIV-infected 
ART-suppressed patient samples differed among the three methods. The semi-nested qPCR detected 
HIV DNA in at least one of the triplicates of 15 out of 20 patients with a detectability of 62% across all 
triplicates (Supplementary Table S2). The QX100 detected target in at least one of the triplicates in all 
patients with an 80% detectability of all triplicates. The Quantstudio detected HIV DNA in all patients 
and did not return an undetermined result in any of the replicates.
As can be inferred from the Bland-Altman analysis, the semi-nested qPCR and the QX100 proved 
most similar: − 0.30 ± 1.22 log10 (95% Limits of Agreement (LoA) of − 2.70 to 2.09 log10), whereas 
agreement between the QX100 and the Quantstudio was found to be − 0.85 ± 1.07 log10 (LoA − 2.96 
to 1.25 log10). The semi-nested qPCR and the Quantstudio had the highest average difference with an 
agreement of − 1.16 ± 1.22 log10 (LoA − 3.54 to 1.23 log10) (Fig. 2). This initial Bland-Altman analysis 
revealed that both the agreement and LoA levels were biased because of the samples with low HIV 
DNA returning one or more undetectable replicates. The actual concentration of HIV DNA per replicate 
reaction in these samples is close to or less than one. In these low ranges, the stochastic sampling error 
causes substantial variation between replicates, which hampers the comparison of different methods36. 
This was statistically confirmed by first regressing the differences between methods on the averages and 
then regressing the absolute values of the residuals on the average between both methods. The latter 
regression was significant, indicating a non-constant variance between both methods (Supplementary 
Figure S1 A–F).
The analysis on a subset of 9 patient samples for which target could be detected in all replicates increased 
the agreement among the three methods (Fig.  2). The semi-nested qPCR and the QX100 had the best 
agreement, being − 0.01 ± 0.32 log10 (LoA − 0.63 to 0.62 log10) and the QX100 and the Quantstudio com-
parison agreed − 0.18 ± 0.35 log10 (LoA − 0.86 to 0.50 log10). The qPCR and the Quantstudio were again 
the least similar methods with an average agreement of − 0.19 ± 0.44 log10 (LoA − 1.04 to 0.67 log10). 
Regression of the absolute values of the residuals on the average between both methods was no longer 
significant in the limited dataset, indicating a constant variance between both methods in this range 
(Supplementary Figure S1 G–I).
Figure 1. Expected and observed values of the dilution series. Input quantity plotted against the observed 
quantities of the dPCR platforms and against the Cq-values of the qPCR. Robust regression analysis reveals 
a quantitative efficiency of 104.5% for the QX100, 74% for the Quantstudio and 93.64% for the qPCR. 
Quantitative linearity is R2 = 0.85 for the QX100, R2 = 0.78 for the Quantstudio and R2 = 0.83 for the qPCR.
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Discussion
Owing to recent technological developments, dPCR is becoming a highly investigated method for abso-
lute quantification of DNA molecules. Although its current implementations do not match the full theo-
retical potential26,37–38, dPCR is theoretically able to deliver direct absolute quantification of DNA copies 
provided a random distribution of samples in equally sized partitions13,14, and recent data show that 
dPCR is more accurate compared to classical qPCR39–41. Here, we evaluated two dPCR platforms with a 
highly sensitive semi-nested qPCR method to quantify HIV DNA in samples with low target abundance. 
Our data show that dPCR can accurately quantify low levels of HIV DNA in patient samples, but that 
semi-nested qPCR may still be preferred for discriminating true positive from false-positive reactions.
The qPCR was the least precise of the three systems with a higher median CV than the QX100 and 
the Quantstudio in both the dilution series (Table 1) and the patient samples (Supplementary Table S3). 
An explanation for this may be found in the nested approach of the qPCR. This approach involves more 
manual handling, rendering it more susceptible to technical bias. In addition, the logarithmic meas-
urement of target abundance performed by qPCR is known to inherently decrease accuracy and preci-
sion11,42. The observation that the QX100 has the best efficiency E = 104.5% and the highest adherence 
Figure 2. Bland-Altman plots of HIV DNA quantification in patient-derived PBMC DNA. Comparing 
qPCR with QX100, qPCR with Quantstudio and QX100 with Quantstudio with all data (filled and open 
circles, bold blue lines) and using only samples with three detectable replicates in all methods (filled circles, 
red lines). Lines indicating mean difference are solid, lines indicating LoA’s are dashed.
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to the robust regression trend line R2 = 0.88 indicates that the QX100 produces the most reliable output 
(Fig. 1). The low efficiency E = 74% of the Quantstudio may be explained by the overestimation of low 
input samples, caused by the presence of false-positive partitions. False-positive detection proved to 
be a severe problem in the Quantstudio. The platform gave positive partitions in both of the PBMC 
DNA NTCs and all of the 8 water NTCs that were tested. None of the PBMC DNA NTCs tested by 
the QX100 or the semi-nested qPCR returned an output, but false-positives were observed in the water 
NTCs tested by the QX100 (Supplementary Table S1). This observation is in accordance with other pub-
lished data11,25,26,43,44 and indicates that the presence of false-positive partitions in the samples cannot be 
excluded with the QX100 either.
Both dPCR platforms overestimated the amount of input DNA, but the bias between the expected 
and observed quantities of the QX100 was substantially lower (median 8.1%) compared to that of the 
Quantstudio (median 28.8%) (Table  1). Bias in the dPCR platforms may be due to the presence of 
false-positive signals. However, it must be noted that an observed dPCR bias could just as well be due to 
a technical error introduced while preparing the dilution series. In addition to this, quantitative bias may 
also be introduced by the underlying algorithm used by the digital PCR software to estimate the amount 
of input template from the concentration of positive to negative partitions. Recent data indicate that dig-
ital PCR partitions have small variations in size and this variation will always lead to an underestimation 
of the input amount of template when the algorithms fails to takes this variation into account38,45. Finally, 
the choice of the threshold may also induce a bias in the dPCR outcome, as a small number of partitions 
with intermediate fluorescence may be falsely classified as positive or negative and may therefore bias the 
quantitative outcome when chosen improperly46,47.
The patient sample quantifications were analyzed by Bland-Altman analysis. Bland-Altman analysis 
is a method for analyzing the agreement between two independent quantifications that is irrespective of 
“true” input quantity. Bland-Altman comparison of platform quantifications of patient-derived samples 
showed that the Quantstudio had the highest average difference with the other methods. Whereas the 
qPCR and the QX100 proved most similar in their average difference and minimal variation across 
all data, the false-positive partitions of the Quantstudio cause the observation of consistently higher 
abundances compared to the other two methods, which is especially obvious in the lower input range 
(Table 1, Fig. 2). The analysis of the limited dataset, from which samples with negative replicates were 
excluded, revealed that the non-constant variance observed in the complete dataset is likely caused by an 
increased variation in the low ranges due to sampling error. Hence, the true limits of agreement between 
the methods will better approach the limits estimated in the sub-analysis, compared to those estimated 
in the initial analysis that includes all samples.
The Bland-Altman analysis of the samples with higher copy numbers still revealed that the Quantstudio 
measured higher quantities than both the qPCR and the QX100 (Fig.  2). These results indicate that 
false-positive partitions impact Quantstudio quantification, both in the higher input ranges as well as in 
samples with low target abundance. Because of these false-positives, neither dPCR platform can provide 
an absolute certainty of the presence or absence of HIV DNA in samples with lowly abundant target. 
Although contamination cannot be excluded, we and others have shown that false-positive partitions can 
arise as artifacts in the QX100. The major drawback of the current dPCR platforms is that these single 
positive partitions cannot be isolated for subsequent analysis (e.g. sequencing) to confirm their artifac-
tual nature or to indicate laboratory contamination. Classical qPCR samples on the other hand allow for 
post-PCR analysis, rendering this method superior to confirm presence or absence of HIV DNA in a 
given sample, regardless of quantification.
The present report indicates equally sensitive quantification of the QX100 compared to a semi-nested 
qPCR. This finding is contrary to earlier reports where dPCR was more sensitive compared to standard 
qPCR26, but in agreement with studies that also used a nested PCR set-up11,25. A properly designed nested 
PCR has a couple of advantages over direct PCR. It allows longer cycling and enrichment of rare target 
in a background of HIV-negative DNA, which effectively increases the limit of detection. Moreover, by 
using an additional primer sequence, the specificity of the assay is substantially enhanced, limiting the 
impact of non-specific amplification or laboratory contamination. A nested set-up with multiple prim-
ers may also be beneficial in dPCR, but the current platforms are unsuitable for the implementation of 
such a PCR set-up. However, this increased sequence specificity may not detect all sequence variants of 
HIV. DPCR may thus have an advantage over nested qPCR in the specific case of HIV, which is known 
to have multiple sequence variants between and within patients. Indeed, it has been shown that dPCR 
performs better than real-time PCR when small sequence variations are present in the priming regions26. 
Even single primer and probe mismatches will affect the accumulation of fluorescence and cause an 
underestimation in qPCR. In dPCR, mismatches will lead to droplets with a lower fluorescence inten-
sity. However, as long as these droplets are above the threshold, they are assigned positive and will not 
affect quantification26,47. This higher tolerance to sequence variation may explain our observation that 
the dPCR platforms detected target in patient samples where the qPCR did not and our observation 
that the dPCR platforms detected higher target abundance than the qPCR. A comparison of multiple 
HIV templates from patients infected with different HIV subtypes should provide more insight into the 
performance of both assays on the quantification of HIV DNA variants in vivo.
In summary, the present findings show that dPCR enables direct and accurate quantification of HIV 
DNA. The QX100 proved equally sensitive as semi-nested qPCR, and superior by having less bias and 
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higher precision, efficiency and quantitative linearity. However, due to the observation of false-positive 
signals with the current dPCR platforms, a semi-nested qPCR may still be preferred in a setup of low 
quantity detection to discriminate between absolute presence or absence of HIV DNA.
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